FDA phase 1 trial shows hydrogel to repair heart is safe to inject in humans -- a first

Scientists successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack. The trial is the first to test a hydrogel designed to repair cardiac tissue. It is also the first to test a hydrogel made from the natural scaffolding of cardiac muscle tissue.

from All Top News -- ScienceDaily https://ift.tt/2LrH4cx